Study of GS-0272 in Participants With Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT06031415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Placebo-Controlled Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of Multiple Ascending Doses of GS-0272 in Adult Participants With Rheumatoid Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goals of this clinical study are to learn more about the study drug, GS-0272, and its safety and tolerability following multiple doses in participants with rheumatoid arthritis (RA). The primary objectives of this study are to assess the safety and tolerability of multiple ascending doses of GS-0272 and to characterize the pharmacokinetics of GS-0272 following multiple doses of GS-0272, in participants with RA.
Study identification
- NCT ID
- NCT06031415
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 28, 2023 (Actual)
- Primary completion
- May 11, 2026 (Actual)
- Completion
- May 11, 2026 (Actual)
- Last update posted
- May 27, 2026
2023 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 6
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis & Rheumatology Associates P.C. | Glendale | California | 85306 | — |
| Stanford School of Medicine, Division of Immunology & Rheumatology | Palo Alto | California | 94304 | — |
| 1238 E. Arrow Hwy | Upland | California | 91786 | — |
| Clinical Research of West Florida, Inc. | Clearwater | Florida | 33765 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Greater Chicago Specialty Physicians/ Clinical Investigation Specialists | Niles | Illinois | 60714 | — |
| Greater Chicago Specialty Physicians/Clinical Investigation Specialists, Inc. | Schaumburg | Illinois | 60195 | — |
| Summit Headlands LLC | Portland | Oregon | 97210 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| PA Regional Center for Arthritis and Osteoporosis Research | Wyomissing | Pennsylvania | 19610 | — |
| Precision Comprehensive Clinical Research Solutions | Colleyville | Texas | 76034 | — |
| Accurate Clinical Research, Inc. | Houston | Texas | 77089 | — |
| Precision Comprehensive Clinical Research Solutions | Irving | Texas | 75061 | — |
| 1600 Republic Parkway | Mesquite | Texas | 75150 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06031415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06031415 live on ClinicalTrials.gov.